Skip to search formSkip to main contentSkip to account menu

pertactin

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
The present study explores the concept of hybrid pertactin (PRN) molecules for immunizing against Bordetella pertussis. New… 
2010
2010
Bordetella pertussis is the causal agent of whooping cough (pertussis), a highly contagious respiratory ill- ness. Although the… 
2009
2009
Antibody decay after a single dose of acellular pertussis vaccine containing 25 μg of pertussis toxin (PT), 25 μg of filamentous… 
2008
2008
The present invention relates to biomedical fields, including transformation and pertactin (Pertactin, Prn) to obtain a protein… 
2006
2006
Pertussis is a highly contagious infectious disease of the respiratory tract which is caused by Bordetella pertussis. Before… 
2005
2005
In Poland vaccination against diphtheria, tetanus and pertussis (DTP) is recommended from 2–3 months of age. Three doses at… 
2001
2001
immunogenic composition comprising a mixture of at least two pertactins or pertactin fragments of Bordetella bronchiseptica… 
1997
1997
Several recently completed trials have shown that acellular pertussis vaccines induce substantial protection against pertussis… 
1997
1997
Abstract Pertactin, which is a membrane-associated antigen of Bordetella pertussis and which is present in many acellular… 
1996
1996
Six NIH Vaccine Treatment and Evaluation Units (VTEUs) enrolled 1340 15- to 20-month-old children to receive one of 12 DTaP or a…